A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT00190775 · COMPLETED
Trial details
- NCT number
- NCT00190775
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2009-07-01
- Enrollment
- 502
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.